What got lost in obesity drug hype
by Lisa Jarvis This year, the incredible potential of obesity medicines like Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Zepbound started to come into view. The drugs work so well for so many that it’s starting to look like they could change the literal and metaphorical ...